Prior to joining TheStreet.com Marc was a Sr. Equity Analyst with Avalon Research. He also worked as a reporter and anchor with ON24. Marc got his start in the equities business as a trading assistant and eventually became a trader with Carlin Equities.
Marc holds a B.A. from the State University of New York at Albany, Series 7, 63, 86, and 87 licenses and has completed the first two levels of the Chartered Market Technicians program.
Unbiased. Uncensored. That's how insider Adam Feuerstein gives you his take on what's hot and what's not in
biotech. You'll get the top picks on his subscriber-only Recommended List — stocks he believes, only after extensive research, have the potential for outsized returns even in this risky sector.